文献速递湿疹皮炎与荨麻疹

自体血清疗法治疗慢性自发性荨麻疹的免疫学效应与潜在机制

Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-05-15

治疗后疾病活动度和生活质量显著改善,且应答者血清IgE-抗IL-24自身抗体水平显著下降,但IgG-抗IL-24无显著变化。提示自体血清疗法可能通过降低IgE-抗IL-24自身抗体发挥免疫学效应。

要点

  • ASST阳性CSU患者接受8周自体血清注射后,UAS7和DLQI在8周和20周时显著改善。
  • 应答者血清IgE-抗IL-24水平显著下降,非应答者无此变化。
  • ASST转阴率与治疗反应无关,BHRA未见显著变化。

核心结论

  • 自体血清疗法可改善ASST阳性CSU患者的疾病活动度和生活质量,其免疫学效应包括降低应答者血清IgE-抗IL-24自身抗体水平。

研究设计与样本

  • 在基线、第9周和第21周评估UAS7、DLQI和ASST,并在基线、第9周、第13周和/或第21周检测血清IgE-抗IL-24、IgG-抗IL-24水平及BHRA。

主要发现

  • 治疗8周和20周后,疾病活动度和生活质量显著改善。
  • BHRA未见显著或相关变化。
  • 应答者血清IgE-抗IL-24水平显著下降,非应答者无显著变化;IgG-抗IL-24水平无显著变化。

临床怎么用

  • 对于ASST阳性的CSU患者,自体血清疗法可能改善症状和生活质量。
  • IgE-抗IL-24自身抗体水平下降可能与治疗应答相关,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Autoimmune processes are considered to play a major role in the pathogenesis of chronic spontaneous urticaria (CSU). Very recently, interleukin 24 (IL-24) has been identified as an immunoglobulin E (IgE) autoantigen in CSU. Some studies revealed that notably autologous serum skin test (ASST)-positive CSU patients may benefit from autohemotherapy; however, the mechanisms of action remain unknown. We aimed to investigate the immunological effects of autologous serum injections in ASST-positive CSU patients. METHODS: Sixty-six ASST-positive CSU patients were treated with weekly intramuscular autologous serum injections for 8 weeks and followed up for 12 weeks. Urticaria activity score (UAS7) and Dermatology Life Quality Index (DLQI) were assessed. The ASST was done at baseline, week 9 and week 21. Serum samples (baseline, weeks 9, 13 and/or 21) were analysed for the levels of IgE-anti-IL-24 and immunoglobulin G (IgG)-anti-IL-24 via ELISA and their ability to release histamine in basophils [basophil histamine release assay (BHRA)]. RESULTS: Autologous serum therapy resulted in a substantial improvement in disease activity and quality of life after 8 and 20 weeks. Twenty-eight percent and 34% of patients turned ASST-negative in weeks 9 and 21, respectively, but there was no link between their response to treatment and changes of ASST results. Also, no significant or relevant changes in BHRA were observed. In contrast, autologous serum therapy significantly decreased IgE-anti-IL-24 serum levels, but not IgG-anti-IL-24 serum levels, in responders but not in non-responders. CONCLUSIONS: Our findings suggest that the immunological effects of autologous serum therapy include a reduction in IgE-anti-IL24 autoantibodies, which may contribute to the pathogenesis of CSU.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Yu L, Buttgereit T, Stahl Skov P, et al. Immunological effects and potential mechanisms of action of autologous serum therapy in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2019. PMID: 31025425. doi:10.1111/jdv.15640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。